XML 18 R7.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Condensed Consolidated Statements of Changes in Equity (unaudited) - USD ($)
$ in Millions
Total
Total Baxter stockholders' equity
Common stock
Common stock in treasury
Additional contributed capital
Retained earnings
Accumulated other comprehensive income (loss)
Noncontrolling interests
Balance, beginning of period (in shares) at Dec. 31, 2022     683,000,000          
Balance, beginning of period (in usd) at Dec. 31, 2022 $ 5,895 $ 5,833 $ 683 $ (11,389) $ 6,322 $ 14,050 $ (3,833) $ 62
Balance, treasury, beginning period (in shares) at Dec. 31, 2022       179,000,000        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income 45 44       44   1
Other comprehensive income (loss) 94 94         94  
Stock issued under employee benefit plans and other (in shares)       (1,000,000)        
Stock issued under employee benefit plans and other 55 55   $ 65 (10)      
Dividends declared on common stock (147) (147)       (147)    
Change in noncontrolling interests (1)             (1)
Balance, end of period (in shares) at Mar. 31, 2023     683,000,000          
Balance, end of period (in usd) at Mar. 31, 2023 5,941 5,879 $ 683 $ (11,324) 6,312 13,947 (3,739) 62
Balance, treasury, ending period (in shares) at Mar. 31, 2023       178,000,000        
Balance, beginning of period (in shares) at Dec. 31, 2023     683,000,000          
Balance, beginning of period (in usd) at Dec. 31, 2023 $ 8,468 8,402 $ 683 $ (11,230) 6,389 16,114 (3,554) 66
Balance, treasury, beginning period (in shares) at Dec. 31, 2023 175,861,893     176,000,000        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income $ 39 37       37   2
Other comprehensive income (loss) (172) (168)         (168) (4)
Stock issued under employee benefit plans and other (in shares)       (2,000,000)        
Stock issued under employee benefit plans and other 50 50   $ 100 (50)      
Dividends declared on common stock (148) (148)       (148)    
Change in noncontrolling interests (2)             (2)
Balance, end of period (in shares) at Mar. 31, 2024     683,000,000          
Balance, end of period (in usd) at Mar. 31, 2024 $ 8,235 $ 8,173 $ 683 $ (11,130) $ 6,339 $ 16,003 $ (3,722) $ 62
Balance, treasury, ending period (in shares) at Mar. 31, 2024 173,930,493     174,000,000